Varied Clinical Presentations of Seven Patients With Mutations inCYP11A1Encoding the Cholesterol Side-Chain Cleavage Enzyme, P450scc
Author(s) -
Meng Kian Tee,
Michal Abramsohn,
Neta Loewenthal,
Mark Harris,
Sudeep Siwach,
Ana Kaplinsky,
Barak Markus,
Ohad S. Birk,
Val C. Sheffield,
Ruti Pavari,
Eli Hershkovitz,
Walter L. Miller
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2828
Subject(s) - cholesterol side chain cleavage enzyme , pregnenolone , steroidogenic acute regulatory protein , adrenodoxin , missense mutation , biology , mutant , compound heterozygosity , reductase , genetics , mutation , gene , medicine , endocrinology , biochemistry , enzyme , cytochrome p450 , steroid , gene expression , messenger rna , hormone
The cholesterol side-chain cleavage enzyme P450scc, encoded by CYP11A1, converts cholesterol to pregnenolone to initiate steroidogenesis. P450scc deficiency can disrupt adrenal and gonadal steroidogenesis, resembling congenital lipoid adrenal hyperplasia clinically and hormonally; only 12 such patients have been reported previously.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom